FDA allocates $2 million for institutions conducting a Human Abuse Potential (HAP) study on botanical Kratom due to rising concerns over its increased use.
With an estimated 1.7 million users in 2021, the study aims to evaluate…
Sorry, this premium content is for RegASK clients only.
Want to access the whole content of the alert or browse all the news?
Subscribe to the latest regulatory news
Curated newsletters
Relevant industry info
Access expert insights